HK1041638A1 - Combination preparation for treating malaria - Google Patents

Combination preparation for treating malaria

Info

Publication number
HK1041638A1
HK1041638A1 HK02102862A HK02102862A HK1041638A1 HK 1041638 A1 HK1041638 A1 HK 1041638A1 HK 02102862 A HK02102862 A HK 02102862A HK 02102862 A HK02102862 A HK 02102862A HK 1041638 A1 HK1041638 A1 HK 1041638A1
Authority
HK
Hong Kong
Prior art keywords
combination preparation
treating malaria
malaria
treating
proguanil
Prior art date
Application number
HK02102862A
Other languages
English (en)
Inventor
Jeffrey David Chulay
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of HK1041638A1 publication Critical patent/HK1041638A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
HK02102862A 1999-04-09 2002-04-16 Combination preparation for treating malaria HK1041638A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12867299P 1999-04-09 1999-04-09
PCT/US2000/009091 WO2000061133A1 (en) 1999-04-09 2000-04-05 Combination preparation for treating malaria

Publications (1)

Publication Number Publication Date
HK1041638A1 true HK1041638A1 (en) 2002-07-19

Family

ID=22436426

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02102862A HK1041638A1 (en) 1999-04-09 2002-04-16 Combination preparation for treating malaria

Country Status (24)

Country Link
US (1) US6413993B1 (xx)
EP (1) EP1171108B1 (xx)
JP (1) JP2002541196A (xx)
KR (1) KR100613805B1 (xx)
CN (1) CN1152676C (xx)
AT (1) ATE241971T1 (xx)
AU (1) AU758167B2 (xx)
BR (1) BR0009676A (xx)
CA (1) CA2369089A1 (xx)
CZ (1) CZ294903B6 (xx)
DE (1) DE60003175T2 (xx)
DK (1) DK1171108T3 (xx)
ES (1) ES2199817T3 (xx)
HK (1) HK1041638A1 (xx)
HU (1) HUP0200842A3 (xx)
IL (2) IL145609A0 (xx)
MX (1) MXPA01010125A (xx)
NO (1) NO20014806L (xx)
NZ (1) NZ514353A (xx)
PL (1) PL350987A1 (xx)
PT (1) PT1171108E (xx)
TR (1) TR200102843T2 (xx)
WO (1) WO2000061133A1 (xx)
ZA (1) ZA200108254B (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9224739D0 (en) * 1992-11-26 1993-01-13 Wellcome Found Medicaments
CN102088956A (zh) * 2008-05-09 2011-06-08 托马有限公司 氯胍用于治疗皮肤/粘膜疾病
EP2318350A4 (en) * 2008-07-25 2012-11-28 Alphapharm Pty Ltd ATOVAQUONE WITH PARTICLE DIAMETER (D90) VARIANT FROM MORE THAN 3 muM TO ABOUT 10 muM
ES2517366T3 (es) 2009-08-20 2014-11-03 Ipca Laboratories Limited Nuevo complejo para el tratamiento y/o profilaxis de infecciones parasitarias
EP3415147A4 (en) * 2016-02-12 2019-07-10 Kao Corporation MELANIN DEGRADATION INHIBITOR
US20200155481A1 (en) * 2017-05-03 2020-05-21 The Johns Hopkins University Intramuscular atovaquone for malaria prophylaxis
CN107737108B (zh) * 2017-12-17 2018-06-26 姚蕾 一种治疗心肌梗死后心室重塑的口服药物组合物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9224739D0 (en) * 1992-11-26 1993-01-13 Wellcome Found Medicaments
JPH0873355A (ja) * 1994-09-02 1996-03-19 Mitsui Toatsu Chem Inc 抗マラリア薬耐性克服剤

Also Published As

Publication number Publication date
CN1346267A (zh) 2002-04-24
AU758167B2 (en) 2003-03-20
PT1171108E (pt) 2003-10-31
ATE241971T1 (de) 2003-06-15
TR200102843T2 (tr) 2002-01-21
EP1171108B1 (en) 2003-06-04
CZ294903B6 (cs) 2005-04-13
JP2002541196A (ja) 2002-12-03
CN1152676C (zh) 2004-06-09
WO2000061133A1 (en) 2000-10-19
DE60003175D1 (de) 2003-07-10
DK1171108T3 (da) 2003-10-06
MXPA01010125A (es) 2002-06-04
IL145609A (en) 2006-04-10
DE60003175T2 (de) 2004-04-01
NZ514353A (en) 2003-10-31
ES2199817T3 (es) 2004-03-01
NO20014806D0 (no) 2001-10-03
US6413993B1 (en) 2002-07-02
AU4202200A (en) 2000-11-14
PL350987A1 (en) 2003-02-24
KR20010108468A (ko) 2001-12-07
HUP0200842A3 (en) 2006-07-28
IL145609A0 (en) 2002-06-30
NO20014806L (no) 2001-12-05
CZ20013646A3 (cs) 2002-06-12
CA2369089A1 (en) 2000-10-19
BR0009676A (pt) 2002-09-03
KR100613805B1 (ko) 2006-08-18
EP1171108A1 (en) 2002-01-16
ZA200108254B (en) 2003-03-26
HUP0200842A2 (hu) 2002-07-29

Similar Documents

Publication Publication Date Title
EP1634601A3 (en) Dietary supplement comprising soyabean, mushroom and mung bean
GEP20053602B (en) Aripiprazole for Oral Administration
MY113059A (en) Controlled-release dosage forms of azithromycin
IL157504A0 (en) Oncolytic virus therapy
HK1047707A1 (zh) (+)-曲馬朵、o-去甲曲馬朵或(+)-o-去甲曲馬朵、o-去甲-n-單-去甲-曲馬朵或(+)-o-去甲-n-單-去甲-曲馬朵治療尿失禁的用途
IL145609A0 (en) Combination preparation for treating malaria
WO1999004772A3 (en) Use of levobupivacaine
MXPA02012064A (es) Complejos de farmaco macromoleculares y composiciones que los contienen.
GB0020504D0 (en) Therapeutic method
HK1024631A1 (en) Use of (+) mefloquine for the treatment of malaria
AU2162202A (en) Antitumor therapy comprising distamycin derivatives
PL357179A1 (en) Use of 2-methyl-thiazolidin-2,4-dicarboxylic acid (2-mtdc) and/or physiologically compatible salts for treating and/or preventing cancers
IL159770A0 (en) Calcium salts with cytotoxic activity
IL153426A0 (en) Method of treating peripheral vascular diseases, peripheral neuropathies, and autonomic neuropathies
USD467344S1 (en) Treatment couch
EP1143981A4 (en) TREATMENT AND PREVENTION OF HIV AND OTHER VIRUS INFECTIONS
EP1347754A4 (en) COMPOSITIONS FOR PREVENTION OF ADHESION
HK1039935A1 (en) Use of (1r, 4s)-4-(6-amino-9h-purin-9-yl)-2-cyclopentene-1-methanol in hbv
WO2003059334A3 (en) Gemcitabine in the treatment of smallpox
IL139064A0 (en) Intermittent claudication therapeutic drugs comprising pyrroloazepines
MD1469F1 (en) Method of treatment of the burn shock
MY126763A (en) Melanoma therapy
EP1908477A3 (en) Combination of temozolomide and pegylated interferon-alpha for treating cancer
UA32358A (uk) Спосіб лікування гіпертонічної хвороби серця
WO2001028533A3 (en) PRODUCTS AND METHODS FOR ACTIVATING PPARη-RXR AND UP-REGULATING MONOCYTE/MACROPHAGE CD36 FOR THE TREATMENT OF MALARIA

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20110405